IL17A and psoriasis: Therapeutic approaches targeting interleukin-17 (IL-17), a key mediator of the Th17-dependent immune pathway, play a crucial role in the treatment of many chronic inflammatory and autoimmune skin diseases, such as psoriasis and hidradenitis suppurativa.